Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data.

Hennessy S, Bilker WB, Knauss JS, Margolis DJ, Kimmel SE, Reynolds RF, Glasser DB, Morrison MF, Strom BL.

BMJ. 2002 Nov 9;325(7372):1070.

2.

Pro re nata medication for psychoses: an audit of practice in two metropolitan hospitals.

Geffen J, Sorensen L, Stokes J, Cameron A, Roberts MS, Geffen L.

Aust N Z J Psychiatry. 2002 Oct;36(5):649-56.

PMID:
12225449
3.

Discontinuation of thioridazine in patients with learning disabilities: balancing cardiovascular toxicity with adverse consequences of changing drugs.

Davies SJ, Cooke LB, Moore AG, Potokar J.

BMJ. 2002 Jun 22;324(7352):1519-21. Review. No abstract available.

4.

Clinically significant drug interactions with antidepressants in the elderly.

Spina E, Scordo MG.

Drugs Aging. 2002;19(4):299-320. Review.

PMID:
12038880
5.

Psychotropics and drug interactions in the elderly patient.

Katona CL.

Int J Geriatr Psychiatry. 2001 Dec;16 Suppl 1:S86-90.

PMID:
11748792
6.

Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential--towards a consensus.

Tucker GT, Houston JB, Huang SM.

Br J Clin Pharmacol. 2001 Jul;52(1):107-17. Review. No abstract available.

7.

Zuclopenthixol acetate in psychiatric emergencies: looking for evidence from clinical trials.

Coutinho E, Fenton M, Adams C, Campbell C.

Schizophr Res. 2000 Dec 15;46(2-3):111-8.

PMID:
11120423
8.

Sudden unexplained death in psychiatric in-patients.

Appleby L, Thomas S, Ferrier N, Lewis G, Shaw J, Amos T.

Br J Psychiatry. 2000 May;176:405-6. No abstract available.

9.

QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients.

Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SH.

Lancet. 2000 Mar 25;355(9209):1048-52.

PMID:
10744090
10.

Polypharmacy in psychiatric treatment. Patterns of psychotropic drug use in Austrian psychiatric clinics.

Rittmannsberger H, Meise U, Schauflinger K, Horvath E, Donat H, Hinterhuber H.

Eur Psychiatry. 1999 Mar;14(1):33-40. Review.

PMID:
10572323
11.
12.
13.

Recent developments in drug metabolism of relevance to psychiatrists.

Pollock BG.

Harv Rev Psychiatry. 1994 Nov-Dec;2(4):204-13. Review.

PMID:
9384903
14.

Paroxetine potentiates the central nervous system side effects of perphenazine: contribution of cytochrome P4502D6 inhibition in vivo.

Ozdemir V, Naranjo CA, Herrmann N, Reed K, Sellers EM, Kalow W.

Clin Pharmacol Ther. 1997 Sep;62(3):334-47.

PMID:
9333110
15.

Hay fever drug to become prescription only.

Wise J.

BMJ. 1997 May 3;314(7090):1299. No abstract available.

16.

Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans.

Hartigan-Go K, Bateman DN, Nyberg G, MÃ¥rtensson E, Thomas SH.

Clin Pharmacol Ther. 1996 Nov;60(5):543-53.

PMID:
8941027
17.

Clinically significant pharmacokinetic drug interactions with carbamazepine. An update.

Spina E, Pisani F, Perucca E.

Clin Pharmacokinet. 1996 Sep;31(3):198-214. Review.

PMID:
8877250
18.
19.

Possible interaction between fluoxetine and pimozide causing sinus bradycardia.

Ahmed I, Dagincourt PG, Miller LG, Shader RI.

Can J Psychiatry. 1993 Feb;38(1):62-3.

PMID:
8448725
20.

A survey of prescribing of psychotropic drugs in a Birmingham psychiatric hospital.

Edwards S, Kumar V.

Br J Psychiatry. 1984 Nov;145:502-7.

PMID:
6149781

Supplemental Content

Support Center